MedicalXpress – One Mouse at a Time: a New Approach to Testing Potential Drugs for Children’s Cancers (Houghton, Kurmasheva, PPTC)
by European Organisation for Research and Treatment of Cancer
A team of researchers in the US and Australia have developed a way of testing potential drugs for children’s cancers so as to take account of the wide genetic diversity of these diseases.
In new research to be presented at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online, Professor Peter Houghton, director of the Greehey Children’s Cancer Research Institute (San Antonio, U.S.), said that instead of conventional testing designs, which use multiple mice as models for rare children’s cancers, the analysis had revealed that it was possible to evaluate.
Related Resource(s):
Related Articles:
- EurekAlert! One mouse at a time: a new approach to testing potential drugs for children’s cancers
- Scienmag Science Magazine: One mouse at a time: a new approach to testing potential drugs for children’s cancers
- InfoSurHoy One mouse at a time: a new approach to testing potential drugs for children’s cancers.
- healthcare-in-europe.com New approach to testing potential drugs for children’s cancers
- Oncology News Australia One mouse at a time: a new approach to testing potential drugs for children’s cancers
- Oncology News Australia ENA 2020: New approach to testing potential drugs for children’s cancers
- Bright Surf: One mouse at a time: a new approach to testing potential drugs for children’s cancers
- BioWorld: ENA 2020: Progress in cancer research can come one mouse at a time, study suggests
- British Society for Haematology: New way to test drugs for children’s cancers
- ECancer: Prospective validation of single mouse testing by the pediatric preclinical testing consortium
Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on childhood cancer by discovering, developing, and disseminating new scientific knowledge. Our mission consists of three key areas — research, clinical, and education.
Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.